[go: up one dir, main page]

HK1019005A1 - Synthetic viscoelastic material for physiological applications such as for ophthalmic applications - Google Patents

Synthetic viscoelastic material for physiological applications such as for ophthalmic applications

Info

Publication number
HK1019005A1
HK1019005A1 HK98115443A HK98115443A HK1019005A1 HK 1019005 A1 HK1019005 A1 HK 1019005A1 HK 98115443 A HK98115443 A HK 98115443A HK 98115443 A HK98115443 A HK 98115443A HK 1019005 A1 HK1019005 A1 HK 1019005A1
Authority
HK
Hong Kong
Prior art keywords
applications
composition
physiological
viscoelastic material
ophthalmic
Prior art date
Application number
HK98115443A
Other languages
English (en)
Inventor
Bradford C Webb
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of HK1019005A1 publication Critical patent/HK1019005A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK98115443A 1993-04-30 1998-12-24 Synthetic viscoelastic material for physiological applications such as for ophthalmic applications HK1019005A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5582293A 1993-04-30 1993-04-30
PCT/US1994/003749 WO1994025004A1 (en) 1993-04-30 1994-04-06 Synthetic viscoelastic material for ophthalmic applications

Publications (1)

Publication Number Publication Date
HK1019005A1 true HK1019005A1 (en) 2000-01-14

Family

ID=22000374

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115443A HK1019005A1 (en) 1993-04-30 1998-12-24 Synthetic viscoelastic material for physiological applications such as for ophthalmic applications

Country Status (13)

Country Link
US (2) US5422376A (xx)
EP (1) EP0732913B1 (xx)
JP (1) JP2976350B2 (xx)
KR (1) KR100246016B1 (xx)
AT (1) ATE233083T1 (xx)
AU (1) AU681146B2 (xx)
CA (1) CA2161774C (xx)
DE (1) DE69432188T2 (xx)
DK (1) DK0732913T3 (xx)
ES (1) ES2192560T3 (xx)
HK (1) HK1019005A1 (xx)
RU (1) RU2145882C1 (xx)
WO (1) WO1994025004A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
AU4741001A (en) 2000-03-14 2001-09-24 Alcon Universal Ltd Viscoelastics for use in middle ear surgery
US20030086899A1 (en) * 2000-03-14 2003-05-08 Jafari Masoud R. Chondroitin sulfate containing viscoelastics for use in treating joints
AU2000268609A1 (en) * 2000-09-14 2002-03-26 Robert Theiler Intraarticular agent for the treatment of osteoarthritis
AU2001298050A1 (en) * 2000-11-06 2002-05-15 Alcon, Inc. Non-aspirating transitional viscoelastics for use in surgery
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
WO2002049552A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Solution for removing cataracts via liquefracture
WO2003011257A1 (en) * 2001-08-01 2003-02-13 Jasjit Singh Composition and process the manufacture of soluble containers with improved gel-strength
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20040101561A1 (en) * 2002-11-13 2004-05-27 Jafari Masoud R. Combinations of viscoelastics for use during surgery
US20120283232A9 (en) * 2003-11-12 2012-11-08 Zhengjun Wang Process for making a pharmaceutical composition
US20050215515A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo Viscoelastic composition, method of use and package
US20060159651A1 (en) * 2005-01-14 2006-07-20 Michael Colvard Gradient molecular weight viscoelastic solutions
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
DE102009037514A1 (de) 2009-08-17 2011-03-10 Dirk-Henning Dr. Menz Wasserlösliche Polysaccharidether und ihre Verwendung
US8845624B2 (en) * 2010-06-25 2014-09-30 Alcon LexSx, Inc. Adaptive patient interface
EP2922919B1 (en) 2012-11-21 2020-03-25 University Of Louisville Research Foundation, Inc. Compositions and methods for reducing oxidative damage
RU2015128609A (ru) * 2012-12-19 2017-01-25 КАШИВ ФАРМА, ЭлЭлСи Перенасыщенные стабилизированные наночастицы для слаборастворимых лекарственных средств
DE102014103512A1 (de) 2014-03-14 2015-09-17 Carl Zeiss Meditec Ag Injektor zur Injektion eines Operations-Hilfsfluids in ein Auge sowie Verfahren zum Erzeugen eines Operations-Hilfsfluids
CA3014030C (en) 2015-02-09 2023-10-03 Ori Braun Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
WO2022172089A1 (en) * 2021-02-12 2022-08-18 I Optima Ltd. Compound, method and system for ophthalmic surgery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
JPS62122671A (ja) * 1985-11-23 1987-06-03 千寿製薬株式会社 眼内手術用高粘性液の製造法
JPH0657245B2 (ja) * 1986-05-14 1994-08-03 ト−メ−産業株式会社 眼科手術用粘弾性溶液
US4819617A (en) * 1986-09-04 1989-04-11 University Of Florida Viscoelastic material for ophthalmic surgery
CA1317226C (en) * 1987-05-04 1993-05-04 Phillip E. Pennell Viscoelastic fluid for ophthalmic surgery and method of using same
US4853374A (en) * 1987-06-09 1989-08-01 M.D.R. Group, Inc. Viscoelastic vitreous substitute with UV blocker
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5218107A (en) * 1991-12-30 1993-06-08 The Dow Chemical Company Removal of undesirable material from water-soluble cellulose ether aqueous solutions

Also Published As

Publication number Publication date
ES2192560T3 (es) 2003-10-16
USRE42243E1 (en) 2011-03-22
JPH09507469A (ja) 1997-07-29
WO1994025004A1 (en) 1994-11-10
EP0732913B1 (en) 2003-02-26
AU6700894A (en) 1994-11-21
ATE233083T1 (de) 2003-03-15
DE69432188T2 (de) 2004-01-22
AU681146B2 (en) 1997-08-21
DE69432188D1 (de) 2003-04-03
CA2161774A1 (en) 1994-11-10
RU2145882C1 (ru) 2000-02-27
JP2976350B2 (ja) 1999-11-10
KR100246016B1 (ko) 2000-04-01
EP0732913A1 (en) 1996-09-25
US5422376A (en) 1995-06-06
DK0732913T3 (da) 2003-06-16
CA2161774C (en) 2000-01-04

Similar Documents

Publication Publication Date Title
HK1019005A1 (en) Synthetic viscoelastic material for physiological applications such as for ophthalmic applications
US4863907A (en) Crosslinked glycosaminoglycans and their use
CA1240929A (en) Chondroitin sulfate/sodium hyaluronate compositions
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
AU1464995A (en) Liquid ophthalmic sustained release delivery system
EP0676207A3 (fr) Agent anticomplémentaire obtenu à partir de fucanes d'algues brunes
ES8507573A1 (es) Procedimiento para la fabricacion de fracciones de acido hialuronico
AU1617897A (en) Ophthalmic solutions viscosified with tamarind seed polysaccharide
TW283716B (xx)
EP0444157A4 (en) Collagen-polymer conjugates
DE69023163D1 (de) Natriumhyaluronat-Zusammensetzung.
HUT61196A (en) Process for producing pharmaceutical composition which may be dropped in the eye
US6051560A (en) Chrondroitin sulfate/sodium hyaluronate composition
AU697005B2 (en) Implantable molded articles for the administration of active substances to plants
AU653371B2 (en) Pharmaceutical compositions
CA2282757A1 (en) Opthalmic composition
AU6559994A (en) Stable moulding or spinning compound containing cellulose
ES8600752A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
JPS6416728A (en) Aqueous preparation
JPH1143446A (ja) 水性製剤の増粘剤
HUT59011A (en) Process for producing composition, and its active ingredient, suitable for inactivating or removing harmful compounds in blood and other extracellular liquids

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20140405